Spiraling insulin costs have created a dangerous barrier for many people with diabetes who need to access lifesaving treatments. The Endocrine Society is calling on stakeholders across the supply chain to help reduce out-of-pocket costs for people with diabetes.
from Latest Science News -- ScienceDaily https://ift.tt/2QcDfrH
via IFTTT
Thursday, November 1, 2018
Supply chain transparency needed to combat soaring insulin costs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment